AI, GenAI, ChatGPT are going to operationalize within the Health System.It's going to focus away from wow, gee whiz, to pragmatic application of technologies embedded within the health system terminals.#digitalhealth #AI #healthtech #startups #bigdata…
Continue Reading
The integration of application programming interfaces (APIs) in electronic health records (EHRs) is on the rise, with 73% of digital health companies leveraging standards-based APIs. ONC’s survey, conducted in collaboration with industry partners, highlights…
Continue Reading
The University of California San Francisco, Office of the National Coordinator for Health Information Technology, the California Health Care Foundation and ScaleHealth developed a survey to learn about application programming interface integrations, barriers faced…
Continue Reading
What You Should Know:
– A new survey reveals that the healthcare industry is making significant strides towards interoperability, thanks to the adoption of standards-based application programming interfaces (APIs).
– The research, conducted by the Office…
Continue Reading
The Office of the National Coordinator for Health IT on Monday announced that the two interoperability alliances have crossed the finish line and are now onboarded as Qualified Health Information Networks capable of nationwide…
Continue Reading
Age-related macular degeneration (AMD) is the leading cause of central vision impairment among the elderly. Effective and accurate AMD screening tools are urgently needed. Indocyanine green angiography (ICGA) is a well-established technique for detecting…
Continue Reading
What You Should Know: ObvioHealth, a global digital clinical trials company, and Oracle Life Sciences are expanding their partnership globally following the results of a year-long, successful effort launching trials in Asia Pacific.The collaboration will enable…
Continue Reading
Care.ai
Booth 1402
Contact: Lexi Lutz, marketing manager
Contact: Jillian Whitefield, business development managerSchedule a meeting with us on Feb 26 or Feb 27 from 8 a.m. – 6 p.m.
CereCore works behind the scenes to…
Would We Do It All Again? Insights from a Designated QHIN Regarding the Application ProcessBy Jay Nakashima
Jay Nakashima, MBA is executive director of EHealth Exchange of Vienna, VA.
I was asked recently,…
Continue Reading
What You Should Know:
– 23andMe Holding Co. (Nasdaq: ME), a genetics and biopharmaceutical company, announced The U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for 23ME-01473 (referred to…
Continue Reading
